SK280261B6 - Chrománový derivát, spôsoby jeho výroby a farmaceu - Google Patents

Chrománový derivát, spôsoby jeho výroby a farmaceu Download PDF

Info

Publication number
SK280261B6
SK280261B6 SK6578-90A SK657890A SK280261B6 SK 280261 B6 SK280261 B6 SK 280261B6 SK 657890 A SK657890 A SK 657890A SK 280261 B6 SK280261 B6 SK 280261B6
Authority
SK
Slovakia
Prior art keywords
group
formula
carbon atoms
alkyl
alkenyl
Prior art date
Application number
SK6578-90A
Other languages
English (en)
Slovak (sk)
Other versions
SK657890A3 (en
Inventor
Lars-Gunnar Larsson
Rolf Noren
Lucy A. Renyi
Svante B. Ross
Daniel D. Sohn
Bj�Rn E. Svensson
Seth O. Thorberg
Original Assignee
Aktiebolaget Astra
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aktiebolaget Astra filed Critical Aktiebolaget Astra
Publication of SK280261B6 publication Critical patent/SK280261B6/sk
Publication of SK657890A3 publication Critical patent/SK657890A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Liquid Crystal Substances (AREA)
  • Bakery Products And Manufacturing Methods Therefor (AREA)
  • Threshing Machine Elements (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Apparatuses For Bulk Treatment Of Fruits And Vegetables And Apparatuses For Preparing Feeds (AREA)
  • Harvester Elements (AREA)
  • Medicinal Preparation (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Curing Cements, Concrete, And Artificial Stone (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
SK6578-90A 1989-12-22 1990-12-21 Chroman derivative, methods for producing the same and pharmaceutical composition containing the same SK657890A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8904361A SE8904361D0 (sv) 1989-12-22 1989-12-22 New chroman and thiochroman derivatives

Publications (2)

Publication Number Publication Date
SK280261B6 true SK280261B6 (sk) 1999-10-08
SK657890A3 SK657890A3 (en) 1999-10-08

Family

ID=20377869

Family Applications (1)

Application Number Title Priority Date Filing Date
SK6578-90A SK657890A3 (en) 1989-12-22 1990-12-21 Chroman derivative, methods for producing the same and pharmaceutical composition containing the same

Country Status (42)

Country Link
EP (1) EP0460169B1 (fr)
JP (1) JP2879972B2 (fr)
KR (1) KR0178991B1 (fr)
CN (1) CN1037438C (fr)
AT (1) ATE138918T1 (fr)
AU (1) AU641204B2 (fr)
CA (1) CA2047237C (fr)
CY (1) CY1991A (fr)
CZ (1) CZ283630B6 (fr)
DE (1) DE69027311T2 (fr)
DK (1) DK0460169T3 (fr)
DZ (1) DZ1469A1 (fr)
EG (1) EG19749A (fr)
ES (1) ES2087993T3 (fr)
FI (1) FI102177B (fr)
GR (1) GR3020497T3 (fr)
HK (1) HK55897A (fr)
HR (1) HRP920851B1 (fr)
HU (1) HU211860A9 (fr)
ID (1) ID945B (fr)
IE (1) IE80753B1 (fr)
IL (1) IL96712A (fr)
IS (1) IS1665B (fr)
LT (1) LT3967B (fr)
LV (2) LV10449B (fr)
MX (1) MX23889A (fr)
NO (1) NO180336C (fr)
NZ (1) NZ236407A (fr)
PH (1) PH30797A (fr)
PL (3) PL164592B1 (fr)
PT (1) PT96304B (fr)
RU (1) RU2092483C1 (fr)
SA (1) SA90110186B1 (fr)
SE (1) SE8904361D0 (fr)
SG (1) SG48043A1 (fr)
SI (1) SI9012429B (fr)
SK (1) SK657890A3 (fr)
TW (1) TW221056B (fr)
UA (1) UA34416C2 (fr)
WO (1) WO1991009853A1 (fr)
YU (2) YU47936B (fr)
ZA (1) ZA909708B (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5420151A (en) * 1989-12-22 1995-05-30 Aktiebolaget Astra Chroman derivatives
ATE149480T1 (de) * 1990-08-15 1997-03-15 Lilly Co Eli Ring-substituierte 2-amino-1,2,3,4-tetra- hydronaphthaline, 3-aminochromane und 3- aminothiochromane
DK0498590T3 (da) * 1991-02-08 1997-05-05 Lilly Co Eli Ringsubstituerede 2-amino-1,2,3,4-tetrahydronaphthalener
HRP920935A2 (en) * 1991-10-08 1995-08-31 Astra Ab New therapeutically active compound
SE9103745D0 (sv) * 1991-12-18 1991-12-18 Wikstroem Haakan Aryl-triflates and related compounds
FR2691149B1 (fr) * 1992-05-18 1994-07-08 Adir Nouveaux composes thiochromaniques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
US5434174A (en) * 1992-07-17 1995-07-18 Eli Lilly And Company Isoxazole derivatives for the treatment of irritable bowel syndrome
SE9301732D0 (sv) * 1993-05-18 1993-05-18 Haakan Wilhelm Wikstroem New centrally acting 5-,6-,7-, and 8-substituted sulphone esters of n-monosubstituted 2-aminotetralins
SE9703378D0 (sv) 1997-09-18 1997-09-18 Astra Ab New compounds
SE9703377D0 (sv) 1997-09-18 1997-09-18 Astra Ab New compounds
US6184226B1 (en) 1998-08-28 2001-02-06 Scios Inc. Quinazoline derivatives as inhibitors of P-38 α
KR20030070917A (ko) * 2001-01-16 2003-09-02 아스트라제네카 아베 치료용 크로만 화합물
KR20080079341A (ko) 2001-01-16 2008-08-29 아스트라제네카 아베 치료용 헤테로시클릭 화합물
KR20030070916A (ko) 2001-01-16 2003-09-02 아스트라제네카 아베 치료용 크로몬 화합물
ATE424825T1 (de) 2001-07-20 2009-03-15 Psychogenics Inc Behandlung von hyperaktivitätsstörungen und aufmerksamkeitsdefiziten
US7125904B2 (en) 2002-10-11 2006-10-24 Portela & C.A., S.A. Peripherally-selective inhibitors of dopamine-β-hydroxylase and method of their preparation
SE0301796D0 (sv) * 2003-06-19 2003-06-19 Astrazeneca Ab New use II
SE0301795D0 (sv) * 2003-06-19 2003-06-19 Astrazeneca Ab New use I
US20080221193A1 (en) * 2006-12-22 2008-09-11 Wyeth 3-amino chromane derivatives
SA08290245B1 (ar) * 2007-04-23 2012-02-12 استرازينيكا ايه بي مشتقات كربو كساميد جديدة من -n (8-اريل رباعي هيدرو نفثالين غير متجانس- 2- يل) أو -n (5-اريل كرومان غير متجانس -3-يل) لعلاج الألم
CN101712672B (zh) * 2008-10-06 2013-02-06 中国中医科学院中药研究所 一种治疗心脑血管系统疾病新化合物及其制备方法、用途
DE102010041948A1 (de) 2010-10-04 2012-04-05 Mahle International Gmbh Filtereinrichtung
GB201316410D0 (en) 2013-09-13 2013-10-30 Bial Portela & Ca Sa Processes for preparing peripherally-selective inhibitors of dopamine-?-hydroxylase and intermediates for use therein

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR862239B (en) * 1985-09-03 1986-12-31 Ciba Geigy Ag 3-amino-dihydro-(1)-benzopyrans and benzothiopyrans
US4801605A (en) * 1986-08-29 1989-01-31 Ciba-Geigy Corporation 3-amino-dihydro-[1]-benzopyrans and benzothiopyrans
SE8605504D0 (sv) * 1986-12-19 1986-12-19 Astra Laekemedel Ab Novel chroman derivatives
US5258287A (en) * 1988-03-22 1993-11-02 Genentech, Inc. DNA encoding and methods of production of insulin-like growth factor binding protein BP53

Also Published As

Publication number Publication date
LTIP1730A (en) 1995-08-25
DE69027311T2 (de) 1996-10-24
NO180336C (no) 1997-04-02
ES2087993T3 (es) 1996-08-01
YU47923B (sh) 1996-05-20
CZ657890A3 (cs) 1998-02-18
IL96712A0 (en) 1991-09-16
UA34416C2 (uk) 2001-03-15
IL96712A (en) 1995-08-31
NO180336B (no) 1996-12-23
IS3662A7 (is) 1991-06-23
CA2047237C (fr) 2003-02-11
IE80753B1 (en) 1999-01-13
YU72191A (sh) 1995-01-31
PL164592B1 (pl) 1994-08-31
EP0460169B1 (fr) 1996-06-05
IE904535A1 (en) 1991-07-03
SI9012429B (sl) 1998-10-31
YU242990A (sh) 1993-10-20
NO913273L (no) 1991-10-08
LV11894B (en) 1998-05-20
SE8904361D0 (sv) 1989-12-22
DZ1469A1 (fr) 2004-09-13
HK55897A (en) 1997-05-09
ZA909708B (en) 1991-08-28
CA2047237A1 (fr) 1991-06-23
LV10449B (en) 1995-10-20
EG19749A (en) 1996-01-31
IS1665B (is) 1997-07-04
ATE138918T1 (de) 1996-06-15
LV11894A (lv) 1997-12-20
FI102177B1 (fi) 1998-10-30
PL164609B1 (en) 1994-08-31
JP2879972B2 (ja) 1999-04-05
PT96304A (pt) 1991-09-30
HRP920851B1 (en) 2000-02-29
PL164608B1 (pl) 1994-08-31
PH30797A (en) 1997-10-17
KR920701193A (ko) 1992-08-11
FI102177B (fi) 1998-10-30
HU211860A9 (en) 1995-12-28
AU6977091A (en) 1991-07-24
CY1991A (en) 1997-09-05
DK0460169T3 (da) 1996-09-23
PT96304B (pt) 1998-09-30
YU47936B (sh) 1996-05-20
HRP920851A2 (en) 1995-10-31
AU641204B2 (en) 1993-09-16
EP0460169A1 (fr) 1991-12-11
WO1991009853A1 (fr) 1991-07-11
CN1037438C (zh) 1998-02-18
TW221056B (fr) 1994-02-11
LT3967B (en) 1996-05-27
GR3020497T3 (en) 1996-10-31
SI9012429A (en) 1997-12-31
JPH04503682A (ja) 1992-07-02
SA90110186B1 (ar) 2001-11-11
LV10449A (lv) 1995-02-20
FI913943A0 (fi) 1991-08-21
MX23889A (es) 1993-10-01
SG48043A1 (en) 1998-04-17
PL293066A1 (en) 1992-08-10
CN1052669A (zh) 1991-07-03
PL293065A1 (en) 1992-08-10
KR0178991B1 (ko) 1999-03-20
NO913273D0 (no) 1991-08-21
SK657890A3 (en) 1999-10-08
ID945B (id) 1996-09-20
NZ236407A (en) 1993-08-26
RU2092483C1 (ru) 1997-10-10
CZ283630B6 (cs) 1998-05-13
DE69027311D1 (en) 1996-07-11

Similar Documents

Publication Publication Date Title
SK280261B6 (sk) Chrománový derivát, spôsoby jeho výroby a farmaceu
US5650524A (en) Process for preparing (R)-3-amino-5-methoxychroman
TWI417100B (zh) 二唑衍生物及其作為代謝型麩胺酸受體增效劑-８４２之用途
JP5042987B2 (ja) トリフルオロメチルベンズアミド誘導体およびその治療上の使用
EP1773770A1 (fr) Derives de indole-2 -carboxamidine utilises comme antagonistes du recepteur nmda
JP7381578B2 (ja) ヒストンデアセチラーゼの二環式阻害剤
JPWO2017155050A1 (ja) 芳香環化合物
KR20030015889A (ko) 신규한 화합물 및 글라이신 전달 억제제로서의 이들의 용도
SK36194A3 (en) 3-(n-isopropyl-n-n-propylamino)-5-(n-isopropyl)- -carbamoylchroman
KR20010101585A (ko) 신규 모르폴리노벤즈아미드 염
JP3786983B2 (ja) ピロリジノン誘導体
JP3786984B2 (ja) ピペラジン誘導体
JP2003510309A (ja) 置換ベンゾイミダゾール誘導体、その製造方法及びその医薬組成物としての使用
JPS6322578A (ja) 活性化合物、その製法及びそれを含む医薬組成物